User considerations in assessing pharmacogenomic tests and their clinical support tools
about
User considerations in assessing pharmacogenomic tests and their clinical support tools
description
scientific article published on 11 September 2018
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2018
@uk
name
User considerations in assessing pharmacogenomic tests and their clinical support tools
@en
User considerations in assessing pharmacogenomic tests and their clinical support tools
@nl
type
label
User considerations in assessing pharmacogenomic tests and their clinical support tools
@en
User considerations in assessing pharmacogenomic tests and their clinical support tools
@nl
prefLabel
User considerations in assessing pharmacogenomic tests and their clinical support tools
@en
User considerations in assessing pharmacogenomic tests and their clinical support tools
@nl
P2093
P2860
P1433
P1476
User considerations in assessing pharmacogenomic tests and their clinical support tools
@en
P2093
Andrea Huston
Boyko Kabakchiev
Gouri Mukerjee
Ron van Schaik
P2860
P2888
P356
10.1038/S41525-018-0065-4
P407
P577
2018-09-11T00:00:00Z